Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Urcuyo Delgado, Gabriela

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca
Urcuyo Delgado, Gabriela

Urcuyo Delgado, Gabriela

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

Entrega del xec solidari de l'associació ImpulsaT

ImpulsaT association awards €20,000 for research into LAMA2-deficient muscular dystrophy

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

Equip de Vall d'Hebron

The FDA approves a treatment co-created at Vall d’Hebron for a rare muscle disease

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

Molècula de DNA

A new clinical algorithm increases the diagnosis rate of rare diseases

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

See more

Related professionals

Cristina de Dios Conde

Cristina de Dios Conde

Tècnic de recerca
Internal Strategy Directorate
Read more
Paula Capilla Fernández

Paula Capilla Fernández

Gestió i Administració
Purchase and Biddings Unit
Finance Directorate
Read more
Rodrigo Vasquez Mercado

Rodrigo Vasquez Mercado

Research technician
Microbiology
Read more
Ana Luiza Barbusa De Souza

Ana Luiza Barbusa De Souza

Predoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.